All sponsors

Multitude Therapeutics Inc.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-31
RECRUITING5
READOUTS ≤12 MONTHS2
Open Multitude Therapeutics Inc. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
AMT-253 for injection
NCT06209580
P1/2RecruitingMalignant Melanoma; Advanced Solid Tumors962026-04-30 (+12 mo)
AMT-116
NCT06782334
P1/2RecruitingAdvanced Solid Tumors1442026-06-30
AMT-116
NCT07590531
P1/2RecruitingAdvanced Non-small Cell Lung Cancer (NSCLC)1182027-05-30
AMT-676
NCT07474727
P2RecruitingColorectal Cancer1802027-09-30
AMT-116
NCT07718737
P2/3RecruitingNSCLC (Advanced Non-small Cell Lung Cancer)5122028-03-30